Jeff Yass’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
Other funds holding TRVI
Jeff Yass's TRVI Position: Q3 2026 in Review
Jeff Yass increased its Trevi Therapeutics (TRVI) stake by 1,366% in Q3 2026, buying an estimated $5.49M and bringing the position to 342,415 shares worth $4.9M. The position accounts for ﹤0.01% of the portfolio, ranked #4476.
Jeff Yass first reported a position in TRVI in Q4 2020 and has held it in 13 quarters since. The position peaked at $14.6M in Q3 2025. 223 funds tracked by Wall St. Rank hold TRVI as of Q3 2026.
- Jeff Yass held 342,415 shares of Trevi Therapeutics worth $4.9M as of Q3 2026.
- Jeff Yass bought 319,065 Trevi Therapeutics shares in Q3 2026, an estimated $5.49M.
- Trevi Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #4476 holding.
- Jeff Yass first reported a position in Trevi Therapeutics in Q4 2020 and has held it in 13 quarters since.
- Jeff Yass's Trevi Therapeutics position peaked at $14.6M in Q3 2025.
- 223 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.